HIF1a protein expression is significantly upregulated in BM MNCs in a subset of MDS patient specimens and high HIF1a expression is associated with worse outcomes in MDS (Tong et al., 2012). This evidence concerns the gene HIF1A and myelodysplastic syndrome.